All In MedTech

Device Trial Radar · NCT04699812

Atrial Fibrillation Algorithms Clinical Validation Study

Last checked: Nov 20, 2026Latest source record: Aug 24, 2022 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

573

Actual

Start

Nov 16, 2020

Primary completion

Apr 19, 2021

Study completion Dec 17, 2021

Sponsor

Lead sponsor
Apple Inc.Not on our public-company list
Sponsor type
Industry
Collaborators
IQVIA Pty Ltd
First posted
Jan 7, 2021

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Non randomized
Model
Parallel
Masking
None
Primary purpose
Screening
FDA-regulated device
Yes
Who can join
All sexes, from 22 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The purpose of the study is to evaluate the performances of investigational Irregular Rhythm Notification Feature (version 2.0) and Atrial Fibrillation History Feature algorithms.

Conditions

  • Atrial Fibrillation

Interventions

  • ELECTROCARDIOGRAM (ECG) PATCH WEARDevice

    ALL PARTICIPANTS WILL WEAR AN ECG PATCH ON THEIR UPPER LEFT CHEST THROUGHOUT THE STUDY PARTICIPATION

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. SENSITIVITY OF IRREGULAR RHYTHM NOTIFICATION FEATURE [IRNF]Time frame: 13 DAYS
  2. SPECIFICITY OF LACK OF IRREGULAR RHYTHM NOTIFICATIONS FEATURE [IRNF]Time frame: 13 DAYS
  3. WEEKLY ATRIAL FIBRILLATION BURDEN FEATURE ESTIMATE [AFBF]Time frame: 13 DAYS

Locations

4 sites in 1 country. Site status is shown where the registry gives one.

  • Clinical Research of South Florida

    Coral Gables, Florida

  • American Health Network of Indiana Llc

    Avon, Indiana

  • Heartland Cardiology Webb

    Wichita, Kansas

1 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.